4-ethylguaiacol has been researched along with Allergic Encephalomyelitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Brown, DA; Furnas, D; Kuo, PC; Paraiso, HC; Scofield, BA; Wang, PY; Weng, WT; Yen, JH; Yu, IC | 1 |
1 other study(ies) available for 4-ethylguaiacol and Allergic Encephalomyelitis
Article | Year |
---|---|
4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Female; Guaiacol; Inflammation; Mice; Mice, Inbred C57BL; Th1 Cells; Th17 Cells | 2021 |